Bristol-Myers Squibb (BMY, $44.7) was a top loser this month, diving -1 to $44.7 per share. Of the 58 stocks analyzed in the Pharmaceuticals: Major Industry throughout this month, of them (2) exhibited an Uptrend while of them (7) were in a Downtrend.